Your browser doesn't support javascript.
loading
Glycoengineered hepatitis B virus-like particles with enhanced immunogenicity.
Joe, Carina C D; Chatterjee, Sayantani; Lovrecz, George; Adams, Timothy E; Thaysen-Andersen, Morten; Walsh, Renae; Locarnini, Stephen A; Smooker, Peter; Netter, Hans J.
Afiliación
  • Joe CCD; Royal Melbourne Institute of Technology (RMIT) University, School of Science, Melbourne, Victoria 3001, Australia; Commonwealth Scientific and Industrial Research Organisation, Clayton, Victoria 3169, Australia.
  • Chatterjee S; Department of Molecular Sciences, Macquarie University, Sydney, New South Wales 2109, Australia.
  • Lovrecz G; Commonwealth Scientific and Industrial Research Organisation, Clayton, Victoria 3169, Australia.
  • Adams TE; Commonwealth Scientific and Industrial Research Organisation, Clayton, Victoria 3169, Australia.
  • Thaysen-Andersen M; Department of Molecular Sciences, Macquarie University, Sydney, New South Wales 2109, Australia.
  • Walsh R; Victorian Infectious Diseases Reference Laboratory (VIDRL), Melbourne Health, The Peter Doherty Institute, Melbourne, Victoria 3000, Australia.
  • Locarnini SA; Victorian Infectious Diseases Reference Laboratory (VIDRL), Melbourne Health, The Peter Doherty Institute, Melbourne, Victoria 3000, Australia.
  • Smooker P; Royal Melbourne Institute of Technology (RMIT) University, School of Science, Melbourne, Victoria 3001, Australia.
  • Netter HJ; Royal Melbourne Institute of Technology (RMIT) University, School of Science, Melbourne, Victoria 3001, Australia; Victorian Infectious Diseases Reference Laboratory (VIDRL), Melbourne Health, The Peter Doherty Institute, Melbourne, Victoria 3000, Australia. Electronic address: hans.netter@mh.org.au
Vaccine ; 38(22): 3892-3901, 2020 05 08.
Article en En | MEDLINE | ID: mdl-32284273
Asunto(s)
Palabras clave
Texto completo
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Colección: 01-internacional Banco de datos: MEDLINE Asunto principal: Vacunas contra Hepatitis B / Vacunas de Partículas Similares a Virus / Inmunogenicidad Vacunal / Hepatitis B Límite: Animals Idioma: En Revista: Vaccine Año: 2020 Tipo del documento: Article País de afiliación: Australia
Texto completo
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Colección: 01-internacional Banco de datos: MEDLINE Asunto principal: Vacunas contra Hepatitis B / Vacunas de Partículas Similares a Virus / Inmunogenicidad Vacunal / Hepatitis B Límite: Animals Idioma: En Revista: Vaccine Año: 2020 Tipo del documento: Article País de afiliación: Australia